Oral contrast agents are barium- or iodine-based and are used for bowel opacification. The concentration of barium determines whether it enhances the diagnosis or causes an artifact and obscures pathology. Different imaging modalities require different concentrations of contrast for optimal detection of pathology.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Oral Contrast Agent industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Market Segment by Product Application
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Finally, the report provides detailed profile and data information analysis of leading company.
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Oral Contrast Agent consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Oral Contrast Agent market by identifying its various subsegments.
3.Focuses on the key global Oral Contrast Agent manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Oral Contrast Agent with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Oral Contrast Agent submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Oral Contrast Agent Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Oral Contrast Agent Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Oral Contrast Agent Segment by Type
2.1.1 Barium-based Contrast Media
2.1.2 Iodinated Contrast Media
2.1.3 Gadolinium-based Contrast Media
2.1.4 Microbubble Contrast Media
2.2 Market Analysis by Application
2.2.1 Cardiovascular Disorders
2.2.2 Cancer
2.2.3 Gastrointestinal Disorders
2.2.4 Musculoskeletal Disorders
2.2.5 Neurological Disorders
2.2.6 Nephrological Disorders
2.3 Global Oral Contrast Agent Market Comparison by Regions (2017-2027)
2.3.1 Global Oral Contrast Agent Market Size (2017-2027)
2.3.2 North America Oral Contrast Agent Status and Prospect (2017-2027)
2.3.3 Europe Oral Contrast Agent Status and Prospect (2017-2027)
2.3.4 China Oral Contrast Agent Status and Prospect (2017-2027)
2.3.5 Japan Oral Contrast Agent Status and Prospect (2017-2027)
2.3.6 Southeast Asia Oral Contrast Agent Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Oral Contrast Agent Industry Impact
2.5.1 Oral Contrast Agent Business Impact Assessment - Covid-19
2.5.2 Market Trends and Oral Contrast Agent Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Oral Contrast Agent Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Oral Contrast Agent Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Oral Contrast Agent Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Oral Contrast Agent Manufacturer Market Share
3.5 Top 10 Oral Contrast Agent Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Oral Contrast Agent Market
3.7 Key Manufacturers Oral Contrast Agent Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Oral Contrast Agent Industry Key Manufacturers
4.1 GE Healthcare (US)
4.1.1 Compan Detail
4.1.2 GE Healthcare (US) Oral Contrast Agent Product Introduction, Application and Specification
4.1.3 GE Healthcare (US) 158 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GE Healthcare (US) News
4.2 Bracco Imaging (Italy)
4.2.1 Compan Detail
4.2.2 Bracco Imaging (Italy) Oral Contrast Agent Product Introduction, Application and Specification
4.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GE Healthcare (US) News
4.3 Bayer HealthCare (Germany)
4.3.1 Compan Detail
4.3.2 Bayer HealthCare (Germany) Oral Contrast Agent Product Introduction, Application and Specification
4.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bayer HealthCare (Germany) News
4.4 Guerbet (France)
4.4.1 Compan Detail
4.4.2 Guerbet (France) Oral Contrast Agent Product Introduction, Application and Specification
4.4.3 Guerbet (France) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Guerbet (France) News
4.5 Lantheus (US)
4.5.1 Compan Detail
4.5.2 Guerbet (France) Oral Contrast Agent Product Introduction, Application and Specification
4.5.3 Lantheus (US) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Lantheus (US) News
4.6 Daiichi Sankyo (Japan)
4.6.1 Compan Detail
4.6.2 Daiichi Sankyo (Japan) Oral Contrast Agent Product Introduction, Application and Specification
4.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Daiichi Sankyo (Japan) News
4.7 Unijules Life Sciences (India)
4.7.1 Compan Detail
4.7.2 Unijules Life Sciences (India) Oral Contrast Agent Product Introduction, Application and Specification
4.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 J.B. Chemicals and Pharmaceuticals (India)
4.8.1 Compan Detail
4.8.2 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Introduction, Application and Specification
4.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 J.B. Chemicals and Pharmaceuticals (India) News
4.9 Spago Nanomedicine (Sweden)
4.9.1 Compan Detail
4.9.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Introduction, Application and Specification
4.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Spago Nanomedicine (Sweden) News
4.10 Taejoon Pharm (South Korea)
4.10.1 Compan Detail
4.10.2 Taejoon Pharm (South Korea) Oral Contrast Agent Product Introduction, Application and Specification
4.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Taejoon Pharm (South Korea) News
4.11 Jodas (India)
4.11.1 Compan Detail
4.11.2 Jodas (India) Oral Contrast Agent Product Introduction, Application and Specification
4.11.3 Jodas (India) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Jodas (India) News
4.12 Magnus Health (India)
4.12.1 Compan Detail
4.12.2 Magnus Health (India) Oral Contrast Agent Product Introduction, Application and Specification
4.12.3 Magnus Health (India) Oral Contrast Agent Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Magnus Health (India) News
5 Global Oral Contrast Agent Market Segment by Big Type
5.1 Global Oral Contrast Agent Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Oral Contrast Agent Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Oral Contrast Agent Revenue and Market Share by Big Type (2017-2022)
5.2 Barium-based Contrast Media Sales Growth Rate and Price
5.2.1 Global Barium-based Contrast Media Sales Growth Rate (2017-2022)
5.2.2 Global Barium-based Contrast Media Price (2017-2022)
5.3 Iodinated Contrast Media Sales Growth Rate and Price
5.3.1 Global Iodinated Contrast Media Sales Growth Rate (2017-2022)
5.3.2 Global Iodinated Contrast Media Price (2017-2022)
5.4 Gadolinium-based Contrast Media Sales Growth Rate and Price
5.4.1 Global Gadolinium-based Contrast Media Sales Growth Rate (2017-2022)
5.4.2 Global Gadolinium-based Contrast Media Price (2017-2022)
5.5 Microbubble Contrast Media Sales Growth Rate and Price
5.5.1 Global Microbubble Contrast Media Sales Growth Rate (2017-2022)
5.5.2 Global Microbubble Contrast Media Price (2017-2022)
6 Global Oral Contrast Agent Market Segment by Big Application
6.1 Global Oral Contrast Agent Sales Market Share by Big Application (2017-2022)
6.2 Cardiovascular Disorders Sales Growth Rate (2017-2022)
6.3 Cancer Sales Growth Rate (2017-2022)
6.4 Gastrointestinal Disorders Sales Growth Rate (2017-2022)
6.5 Musculoskeletal Disorders Sales Growth Rate (2017-2022)
6.6 Neurological Disorders Sales Growth Rate (2017-2022)
6.7 Nephrological Disorders Sales Growth Rate (2017-2022)
7 Global Oral Contrast Agent Forecast
7.1 Global Oral Contrast Agent Revenue, Sales and Growth Rate (2022-2027)
7.2 Oral Contrast Agent Market Forecast by Regions (2022-2027)
7.2.1 North America Oral Contrast Agent Market Forecast (2022-2027)
7.2.2 Europe Oral Contrast Agent Market Forecast (2022-2027)
7.2.3 China Oral Contrast Agent Market Forecast (2022-2027)
7.2.4 Japan Oral Contrast Agent Market Forecast (2022-2027)
7.2.5 Southeast Asia Oral Contrast Agent Market Forecast (2022-2027)
7.2.6 Other Regions Oral Contrast Agent Market Forecast (2022-2027)
7.3 Oral Contrast Agent Market Forecast by Type (2022-2027)
7.3.1 Global Oral Contrast Agent Sales Forecast by Type (2022-2027)
7.3.2 Global Oral Contrast Agent Market Share Forecast by Type (2022-2027)
7.4 Oral Contrast Agent Market Forecast by Application (2022-2027)
7.4.1 Global Oral Contrast Agent Sales Forecast by Application (2022-2027)
7.4.2 Global Oral Contrast Agent Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Oral Contrast Agent Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Oral Contrast Agent Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Oral Contrast Agent
Figure Market Concentration Ratio and Market Maturity Analysis of Oral Contrast Agent
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Oral Contrast Agent Market Size by Big Type
Figure Global Market Share of Oral Contrast Agent by Big Type in 2021
Figure Barium-based Contrast Media Picture (2017-2022)
Figure Iodinated Contrast Media Picture (2017-2022)
Figure Gadolinium-based Contrast Media Picture (2017-2022)
Global Oral Contrast Agent Market Size by Big Application
Table Global Oral Contrast Agent Market Size by Application
Figure Global Oral Contrast Agent Market Share by Big Application in 2021
Figure Cardiovascular Disorders Picture
Figure Cancer Picture
Figure Gastrointestinal Disorders Picture
Figure Musculoskeletal Disorders Picture
Figure Neurological Disorders Picture
Figure Nephrological Disorders Picture
Table Global Oral Contrast Agent Comparison by Regions (M USD) (2017-2027)
Figure Global Oral Contrast Agent Market Size (Million US$) (2017-2027)
Figure North America Oral Contrast Agent Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Oral Contrast Agent Revenue (Million US$) Growth Rate (2017-2027)
Figure China Oral Contrast Agent Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Oral Contrast Agent Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Oral Contrast Agent Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Oral Contrast Agent Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Oral Contrast Agent Sales by Manufacturer (2017-2022)
Figure Global Oral Contrast Agent Sales Market Share by Manufacturer in 2021
Table Global Oral Contrast Agent Revenue by Manufacturer (2017-2022)
Figure Global Oral Contrast Agent Revenue Market Share by Manufacturer in 2021
Table Global Oral Contrast Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oral Contrast Agent Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Oral Contrast Agent Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Oral Contrast Agent Market
Table Key Manufacturers Oral Contrast Agent Product Type
Table Mergers & Acquisitions Planning
Table GE Healthcare (US) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of GE Healthcare (US)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bracco Imaging (Italy) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Bracco Imaging (Italy)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bracco Imaging (Italy) Recent Development
Table Bayer HealthCare (Germany) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Bayer HealthCare (Germany)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer HealthCare (Germany) Main Business
Table Bayer HealthCare (Germany) Recent Development
Table Guerbet (France) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Guerbet (France)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Guerbet (France) Main Business
Table Guerbet (France) Recent Development
Table Guerbet (France) Main Business
Table Guerbet (France) Recent Development
Table Lantheus (US) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Lantheus (US)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lantheus (US) Main Business
Table Lantheus (US) Recent Development
Table Daiichi Sankyo (Japan) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Daiichi Sankyo (Japan)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Daiichi Sankyo (Japan) Main Business
Table Daiichi Sankyo (Japan) Recent Development
Table Unijules Life Sciences (India) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Unijules Life Sciences (India)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Unijules Life Sciences (India) Main Business
Table Unijules Life Sciences (India) Recent Development
Table J.B. Chemicals and Pharmaceuticals (India) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of J.B. Chemicals and Pharmaceuticals (India)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table J.B. Chemicals and Pharmaceuticals (India) Main Business
Table J.B. Chemicals and Pharmaceuticals (India) Recent Development
Table Spago Nanomedicine (Sweden) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Spago Nanomedicine (Sweden)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Spago Nanomedicine (Sweden) Main Business
Table Spago Nanomedicine (Sweden) Recent Development
Table Taejoon Pharm (South Korea) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Taejoon Pharm (South Korea)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taejoon Pharm (South Korea) Main Business
Table Taejoon Pharm (South Korea) Recent Development
Table Jodas (India) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Jodas (India)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jodas (India) Main Business
Table Jodas (India) Recent Development
Table Magnus Health (India) Company Profile
Table Oral Contrast Agent Product Introduction, Application and Specification of Magnus Health (India)
Table Oral Contrast Agent Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Magnus Health (India) Main Business
Table Magnus Health (India) Recent Development
Figure Global Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure Global Oral Contrast Agent Revenue and Growth Rate (2017-2022)
Table Global Oral Contrast Agent Sales by Regions (2017-2022)
Figure Global Oral Contrast Agent Sales Market Share by Regions in 2021
Table Global Oral Contrast Agent Revenue by Regions (2017-2022)
Figure Global Oral Contrast Agent Revenue Market Share by Regions in 2021
Figure North America Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure Europe Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure China Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure Japan Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure Southeast Asia Oral Contrast Agent Sales and Growth Rate (2017-2022)
Figure Other Regions Oral Contrast Agent Sales and Growth Rate (2017-2022)
Table Global Oral Contrast Agent Sales by Big Type (2017-2022)
Table Global Oral Contrast Agent Sales Market Share by Big Type (2017-2022)
Figure Global Oral Contrast Agent Sales Market Share by Big Type in 2019
Table Global Oral Contrast Agent Revenue by Big Type (2017-2022)
Table Global Oral Contrast Agent Revenue Market Share by Big Type (2017-2022)
Table Global Oral Contrast Agent Revenue Market Share by Big Type in 2019
Figure Global Barium-based Contrast Media Sales Growth Rate (2017-2022)
Figure Global Barium-based Contrast Media Price (2017-2022)
Figure Global Iodinated Contrast Media Sales Growth Rate (2017-2022)
Figure Global Iodinated Contrast Media Price (2017-2022)
Figure Global Gadolinium-based Contrast Media Sales Growth Rate (2017-2022)
Figure Global Gadolinium-based Contrast Media Price (2017-2022)
Figure Global Microbubble Contrast Media Sales Growth Rate (2017-2022)
Table Global Oral Contrast Agent Sales by Big Application (2017-2022)
Table Global Oral Contrast Agent Sales Market Share by Big Application (2017-2022)
Figure Global Oral Contrast Agent Sales Market Share by Big Application in 2019
Figure Global Cardiovascular Disorders Sales Growth Rate (2017-2022)
Figure Global Cancer Sales Growth Rate (2017-2022)
Figure Global Gastrointestinal Disorders Sales Growth Rate (2017-2022)
Figure Global Musculoskeletal Disorders Sales Growth Rate (2017-2022)
Figure Global Neurological Disorders Sales Growth Rate (2017-2022)
Figure Global Nephrological Disorders Sales Growth Rate (2017-2022)
Figure Global Oral Contrast Agent Sales and Growth Rate (2022-2027)
Figure Global Oral Contrast Agent Revenue and Growth Rate (2022-2027)
Table Global Oral Contrast Agent Sales Forecast by Regions (2022-2027)
Table Global Oral Contrast Agent Market Share Forecast by Regions (2022-2027)
Figure North America Sales Oral Contrast Agent Market Forecast (2022-2027)
Figure Europe Sales Oral Contrast Agent Market Forecast (2022-2027)
Figure China Sales Oral Contrast Agent Market Forecast (2022-2027)
Figure Japan Sales Oral Contrast Agent Market Forecast (2022-2027)
Figure Southeast Asia Sales Oral Contrast Agent Market Forecast (2022-2027)
Figure Other Regions Sales Oral Contrast Agent Market Forecast (2022-2027)
Table Global Oral Contrast Agent Sales Forecast by Type (2022-2027)
Table Global Oral Contrast Agent Market Share Forecast by Type (2022-2027)
Table Global Oral Contrast Agent Sales Forecast by Application (2022-2027)
Table Global Oral Contrast Agent Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Contrast Agent
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Oral Contrast Agent Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Oral Contrast Agent Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Oral Contrast Agent Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Oral Contrast Agent Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Oral Contrast Agent Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Oral Contrast Agent Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Oral Contrast Agent Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Oral Contrast Agent Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)